Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
The CAS number for BPC-157 is 137525-51-0, which uniquely identifies the compound for research and regulatory reference
Professional Treatments Consider integrating GHK-Cu with clinical procedures like PRP, GFC (Growth Factor Concentrate), or exosome therapy for enhanced regrowth and scalp rejuvenation
An intra-articular knee series with 16 patients analysed
Where Phase I or Phase II human trials exist, they are noted in the compound page summary
A small number of human studies from the 1980s and 1990s reported improvements in sleep architecture and reduced insomnia symptoms, but these trials had very small sample sizes (often under 20 subjects), lacked rigorous controls, and have not been replicated with modern methodology
